SCHEMBL7822684

SCHEMBL7822684

Cn1c(CO)nc2cc(Cl)cnc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.42
HTT P42858 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TBXA2R P21731 2/20 0.42
KMT2A Q03164 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
PABPC1 P11940 1/20 0.41
RHEB Q15382 1/20 0.40
BRD4 O60885 1/20 0.36
DRD4 P21917 1/20 0.33
GRM2 Q14416 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TRPM5 Q9NZQ8 2/20 0.32
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12930107 0.83 PDE10A (0.41) HSD17B10KMT2ALMNAMEN1RHEB
SCHEMBL7831798 0.81 HSD17B10 (0.42) HPGDHTTHSD17B10KMT2ALMNA
SCHEMBL1050215 0.81 BRD4 (0.36) HPGDHTTTBXA2RRHEBBRD4
SCHEMBL18022583 0.79 TBXA2R (0.42) HPGDHTTHSD17B10TBXA2RKMT2A
SCHEMBL12354237 0.78 HSD17B10 (0.46) HPGDHTTHSD17B10TBXA2RKMT2A
SCHEMBL12354238 0.78 HSD17B10 (0.49) HPGDHTTHSD17B10TBXA2RKMT2A
SCHEMBL20508589 0.76 HSD17B10 (0.47) HPGDHTTHSD17B10TBXA2RKMT2A
SCHEMBL25994806 0.74 TBXA2R (0.39) HPGDHTTHSD17B10TBXA2RKMT2A
SCHEMBL7833453 0.73 CYP1A2 (0.46) HSD17B10KMT2ALMNAMEN1MAPK1
SCHEMBL21877942 0.73 TBXA2R (0.42) TBXA2RKMT2ALMNAMEN1RHEB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed